Zhejiang Medicine Co., Ltd.

Shanghai Stock Exchange 600216.SS

Zhejiang Medicine Co., Ltd. EPS (Diluted) for the year ending December 31, 2023: USD 0.06

Zhejiang Medicine Co., Ltd. EPS (Diluted) is USD 0.06 for the year ending December 31, 2023, a 15.10% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Zhejiang Medicine Co., Ltd. EPS (Diluted) for the year ending December 31, 2022 was USD 0.06, a -67.90% change year over year.
Zhejiang Medicine Co., Ltd. EPS (Diluted) for the year ending December 31, 2021 was USD 0.17, a 49.30% change year over year.
Zhejiang Medicine Co., Ltd. EPS (Diluted) for the year ending December 31, 2020 was USD 0.11, a 122.26% change year over year.
Zhejiang Medicine Co., Ltd. EPS (Diluted) for the year ending December 31, 2019 was USD 0.05, a -6.44% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

Shanghai Stock Exchange: 600216.SS

Zhejiang Medicine Co., Ltd.

CEO	Mr. Chun Lei Lu
IPO Date	Oct. 21, 1999
Location	China
Headquarters	168 Zhiyuan Middle Avenue
Employees	6,227
Sector	Healthcare
Industries Pharmaceuticals Baby & Childcare Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care Pet Food Plastics

Description

Zhejiang Medicine Co., Ltd. produces and sells life nutrition and pharmaceutical products in China. The company offers life nutrition products, such as synthetic vitamin E, vitamin A, natural vitamin E, vitamin H, vitamin D3, coenzyme Q10, carotene, cantharidin, lutein, lycopene, and other vitamins and vitamin products. It also provides pharmaceutical manufacturing products, including anti-drug resistant antibiotics, anti-malaria and other pharmaceutical raw materials, quinolones, and anti-drug resistant products; and pharmaceutical products comprising sugars and hormones. The company was founded in 1997 and is headquartered in Shaoxing, China.

Key trends

Past 5 years